109 filings
Page 5 of 6
8-K
aa61v6fr98qmyx5zv5ye
14 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K/A
8dlkfn2jvqpo
9 Jan 18
Other Events
12:00am
8-K
97vuwr1 46
8 Jan 18
Other Events
12:00am
8-K
lr0if5o
21 Dec 17
Material Modifications to Rights of Security Holders
12:00am
8-K
ovpwv4210vxtu2
6 Dec 17
Other Events
12:00am
8-K
0yjlo 1lhq
2 Nov 17
Axovant Announces Second Fiscal Quarter Financial Results and Corporate Updates
12:00am
8-K
ueuzv52i btc
3 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
dy9sqsxi n750h
26 Sep 17
Axovant Announces Negative Topline Results of Intepirdine
12:00am
8-K
d1cbf
22 Aug 17
Departure of Directors or Certain Officers
12:00am
8-K
mw4 we0z7huci5
21 Aug 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
1r788s
7 Aug 17
Axovant Announces Fiscal First Quarter Financial Results and Corporate Updates
12:00am
8-K
vxcnxzx 47
13 Jun 17
Axovant Sciences Announces Fiscal Year-End Financial Results and Corporate Updates
12:00am
8-K
tqjxd1s
6 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
h18 sgijx6xx26cjpa
13 Apr 17
Other Events
12:00am
8-K
b83hkd5g6f
10 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
glakv v0u
14 Feb 17
Results of Operations and Financial Condition
12:00am
8-K
9knkw
13 Feb 17
Other Events
12:00am
8-K
0hav8x ikvj8m
3 Feb 17
Axovant Sciences Announces $55.0 Million Venture Debt Financing from Hercules Capital
12:00am
8-K
du3jia57 d54q1vz4
9 Jan 17
Axovant Sciences Announces Pipeline Program Updates and Presentation at 35th Annual J.P. Morgan Conference
12:00am
8-K
oixz4d27m3dga
7 Nov 16
Results of Operations and Financial Condition
12:00am